101 related articles for article (PubMed ID: 8361766)
1. I kappa B alpha can localize in the nucleus but shows no direct transactivation potential.
Cressman DE; Taub R
Oncogene; 1993 Sep; 8(9):2567-73. PubMed ID: 8361766
[TBL] [Abstract][Full Text] [Related]
2. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.
Wulczyn FG; Naumann M; Scheidereit C
Nature; 1992 Aug; 358(6387):597-9. PubMed ID: 1501714
[TBL] [Abstract][Full Text] [Related]
3. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.
Aoudjit F; Brochu N; Bélanger B; Stratowa C; Hiscott J; Audette M
Cell Growth Differ; 1997 Mar; 8(3):335-42. PubMed ID: 9056676
[TBL] [Abstract][Full Text] [Related]
4. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.
Whiteside ST; Epinat JC; Rice NR; Israël A
EMBO J; 1997 Mar; 16(6):1413-26. PubMed ID: 9135156
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
[TBL] [Abstract][Full Text] [Related]
6. Induction of nuclear factor-kappa B during primary B cell differentiation.
Kistler B; Rolink A; Marienfeld R; Neumann M; Wirth T
J Immunol; 1998 Mar; 160(5):2308-17. PubMed ID: 9498771
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of growth inhibition by GAL4-L kappa B-alpha in Saccharomyces cerevisiae.
Morin PJ; Downs JA; Snodgrass AM; Gilmore TD
Cell Growth Differ; 1995 Jul; 6(7):789-98. PubMed ID: 7547500
[TBL] [Abstract][Full Text] [Related]
8. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B.
Goto M; Yamada K; Katayama K; Tanaka I
Mol Pharmacol; 1996 May; 49(5):860-73. PubMed ID: 8622636
[TBL] [Abstract][Full Text] [Related]
10. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.
Franzoso G; Bours V; Park S; Tomita-Yamaguchi M; Kelly K; Siebenlist U
Nature; 1992 Sep; 359(6393):339-42. PubMed ID: 1406939
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
12. Cooperative binding and synergistic activation by RelA and C/EBPbeta on the intercellular adhesion molecule-1 promoter.
Catron KM; Brickwood JR; Shang C; Li Y; Shannon MF; Parks TP
Cell Growth Differ; 1998 Nov; 9(11):949-59. PubMed ID: 9831247
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
Harhaj E; Blaney J; Millhouse S; Sun SC
Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
[TBL] [Abstract][Full Text] [Related]
14. Transcription of the RelB gene is regulated by NF-kappaB.
Bren GD; Solan NJ; Miyoshi H; Pennington KN; Pobst LJ; Paya CV
Oncogene; 2001 Nov; 20(53):7722-33. PubMed ID: 11753650
[TBL] [Abstract][Full Text] [Related]
15. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
Hsing Y; Hostager BS; Bishop GA
J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100.
Dobrzanski P; Ryseck RP; Bravo R
Oncogene; 1995 Mar; 10(5):1003-7. PubMed ID: 7898917
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
18. Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B.
Kerr LD; Ransone LJ; Wamsley P; Schmitt MJ; Boyer TG; Zhou Q; Berk AJ; Verma IM
Nature; 1993 Sep; 365(6445):412-9. PubMed ID: 8413585
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional repression by the proto-oncogene BCL-6.
Seyfert VL; Allman D; He Y; Staudt LM
Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
[TBL] [Abstract][Full Text] [Related]
20. Human T cell leukemia virus type 1 tax protein increases NF-kappa B dimer formation and antagonizes the inhibitory activity of the I kappa B alpha regulatory protein.
Petropoulos L; Lin R; Hiscott J
Virology; 1996 Nov; 225(1):52-64. PubMed ID: 8918533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
